Goldman Sachs Group Inc Bristol Myers Squibb CO Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 13,245,219 shares of BMY stock, worth $637 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
13,245,219
Previous 14,051,319
5.74%
Holding current value
$637 Million
Previous $857 Million
5.74%
% of portfolio
0.14%
Previous 0.14%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.2 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.63 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.2 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.56 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...